Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia

Y. Horimasu, N. Ishikawa, T. Nakashima, H. Iwamoto, T. Senoo, S. Ohshimo, K. Fujitaka, Y. Haruta, H. Murai, N. Hattori, N. Kohno (Hiroshima, Japan)

Source: International Congress 2014 – ILDs 3
Session: ILDs 3
Session type: Thematic Poster Session
Number: 774
Disease area: Interstitial lung diseases

Congress or journal article abstract

Abstract

Background: Chronic hypersensitivity pneumonia (CHP) is characterized by varying degrees of inflammation and progressing fibrosis of the lung caused by persistent exposure to a variety of inhaled antigens. The prognosis of patients with CHP who show fibrosing change in their lung tissue have been reported to be as poor as that of the patients with idiopathic pulmonary fibrosis (IPF). Annual changes in forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DLCO) have been reported to predict the outcome of patients with IPF.Aim: We conducted this study to clarify whether annual changes in FVC and/or DLCO can predict the prognosis of the patients with CHP.Methods: We retrospectively recruited 45 patients with CHP. Spirometry and DLCO measurements were made by one specialized technician, and annual declines in both FVC and DLCO were calculated as the slope of the regression line.Results: Median overall survival time of 45 patients with CHP was 1891±203.5 days. The mean annual declines in FVC and DLCO were 165.4±46.1 ml/year and 0.92±0.41 ml/year, respectively. The Cox proportional-hazards regression analyses revealed that more than 10% of annual decline in FVC and more than 15% of annual decline in DLCO were significant predictors of poor overall survival (P=0.001 and P=0.001, respectively). Furthermore, multivariate analyses revealed that annual changes in both FVC and DLCO are independent prognostic factor for the patients with CHP even after adjusted by other covariates.Conclusion: In the present study, we demonstrated that the annual changes in pulmonary function could independently predict the prognosis of the patients with CHP.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Horimasu, N. Ishikawa, T. Nakashima, H. Iwamoto, T. Senoo, S. Ohshimo, K. Fujitaka, Y. Haruta, H. Murai, N. Hattori, N. Kohno (Hiroshima, Japan). Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia. Eur Respir J 2014; 44: Suppl. 58, 774

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014

Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014

Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases
Source: International Congress 2014 – ILDs 4
Year: 2014

Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 6
Year: 2014

Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014


The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014


Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 6
Year: 2014


Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
Source: International Congress 2014 – ILDs 6
Year: 2014

Cryptogenic organising pneumonia focusing on its prognostic determinants
Source: International Congress 2014 – ILDs 4
Year: 2014


The role of CCR2+CD4+T cells in lung fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014

6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014


Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


Evolution of an interstitial lung disease MDT: 5.5 years of data
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014